Our observations regarding CD34 are (1) that CD34+/ColI+ cells are prevalent in the lung tissue and peripheral blood of SSc-ILD patients, and (2) in agreement with other investigators [7,26], these CD34+ peripheral blood cells from SSc-ILD patients can be either CD14+ or CD14-. The gene discussed is CD14; the disease is systemic sclerosis.